Brodalumab
Based on 4 publication(s) in Google Scholar
Brodalumab (AMG 827) is a human anti-interleukin-17-receptor IgG2 monoclonal antibody that can be used for the research of moderate-to-severe plaque psoriasis and rheumatoid arthritis.
For research use only. We do not sell to patients.
- Purity: 99.18%
- CAS No.: 1174395-19-7
- Molecular Weight:144.06 kDa
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications Citing Use of MedChemExpress (MCE) Brodalumab
More-
In Vivo Efficacy Study
-
Histological Imaging/Staining
-
WB
-
IF
-
Histological Imaging/Staining
Biological Activity
Human IgG2 kappa
Human
IL-17Ra/CD217
Brodalumab (AMG 827) blocks the biological activity of IL-17A, IL-17F and IL17-A/F heterodimer signaling through the IL-17RA/RC complex, as well as IL-25 (IL-17E) signaling through the IL-17RA/RB complex[2].
Brodalumab is capable of inhibiting the inflammatory process in psoriasis[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | Plexxikon| | 2011-05 | PHASE1 |
Unconjugated
The product can be reconstituted/diluted with sterile PBS or saline.
-
Human IgG2 kappa
ELISA, FACS, Functional assay
-
Immobilized IL-17RA Protein, Human can bind Brodalumab. The EC50 for this effect is 7.1 ng/mL. -
Flow cytometric analysis of 1X106 K562 cells with Brodalumab (HY-P9925, red). Cells were fixed with 4% paraformaldehyde. Then stained with the primary antibody at 1/200 dilution for an hour at 4℃. Alexa Fluor 488-conjugated AffiniPure Goat Anti-Human IgG H&L (HY-P83776) was used as the secondary antibody at 1/1,000 dilution for 30 minutes at 4℃. Human IgG2 kappa (HY-P99002, blue) was used as the isotype control, cells without incubation with primary antibody were used as the unlabeled control (black).
Chemical Information
-
CAS No. 1174395-19-7
-
Appearance Liquid
-
Molecular Weight 144.06 kDa
-
Color Colorless to light yellow
-
SMILES
[Brodalumab]
-
Synonyms
AMG 827; KHK4827
-
Shipping
Shipping with dry ice.
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications (4)
-
Journal Impact Factor
-
Most Recent
-
Adv Sci (Weinh)
Aberrant Chitinase 3-Like 1 Expression in Basal Cells Contributes to Systemic Sclerosis Fibrosis. [Abstract]2025 Feb;12(6):e2310169. PMID: 39686726
Brodalumab purchased from MedChemExpress. Usage Cited in: Adv Sci (Weinh). 2025 Feb;12(6):e2310169. [Abstract]
Representative skin ultrasound images in corresponding groups. Quantification of dermal thickness is shown at the bottom. Anti-IL-17RA mAb (Brodalumab; 200 μg; s.c.; once weekly on days 1, 8, and 15) reduced dermal thickness in the skin of BLM-SSc mice compared with isotype control IgG.
Brodalumab purchased from MedChemExpress. Usage Cited in: Adv Sci (Weinh). 2025 Feb;12(6):e2310169. [Abstract]
Brodalumab (anti-IL-17RA mAb; 200 μg; s.c.; once weekly on days 1, 8, and 15). (i) Representative HE (left) and Masson (right) staining of skin corresponding groups. (ii) Quantification of dermal thickness. (iii) Hydroxyproline contents of skin samples.
Brodalumab purchased from MedChemExpress. Usage Cited in: Adv Sci (Weinh). 2025 Feb;12(6):e2310169. [Abstract]
Representative WB images of indicated proteins in skin samples of each group. Brodalumab (anti-IL-17RA mAb; 200 μg; s.c.; once weekly on days 1, 8, and 15) reduced α-SMA and Col1A1 expression and downregulated NF-κB/MAPK pathway-related phosphorylated proteins in the skin of BLM-SSc mice.
Brodalumab purchased from MedChemExpress. Usage Cited in: Adv Sci (Weinh). 2025 Feb;12(6):e2310169. [Abstract]
Representative immunofluorescence images of skin stained with indicated antibodies in corresponding groups. Brodalumab (anti‐IL‐17RA mAb; 200 μg; s.c.; once weekly on days 1, 8, and 15) reduced α-SMA and Col1A1 fluorescence signals in the skin of BLM-SSc mice.
-
Adv Sci (Weinh)
Gingerenone A Attenuates Ulcerative Colitis via Targeting IL-17RA to Inhibit Inflammation and Restore Intestinal Barrier Function. [Abstract]2024 Jul;11(28):e2400206. PMID: 38639442 -
J Agric Food Chem
Atractylenolide III Ameliorates Ulcerative Colitis By Targeting IL-17RA to Suppress Macrophage M1 Polarization. [Abstract]2025 Dec 3;73(48):30761-30776. PMID: 41251394
Brodalumab purchased from MedChemExpress. Usage Cited in: J Agric Food Chem. 2025 Dec 3;73(48):30761-30776. [Abstract]
Images of H&E staining. Brodalumab (0.5 mg/kg; i.p.; once daily for 7 days; mice) restored colonic crypt and goblet cell structures and reduced inflammatory cell infiltration.
-
Purity & Documentation
-
Data Sheet (260 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Inhibitory Antibodies User Guide (603 KB)
References
[1]. Papp KA, et al. Brodalumab, an anti-interleukin-17-receptor antibody for psoriasis. N Engl J Med. 2012 Mar 29;366(13):1181-9. [Content Brief]
[2]. Martin DA, et al. A phase Ib multiple ascending dose study evaluating safety, pharmacokinetics, and early clinical response of brodalumab, a human anti-IL-17R antibody, in methotrexate-resistant rheumatoid arthritis. Arthritis Res Ther. 2013 Oct 25;15(5):R164. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)